Attenuation of toll‐like receptor 2‐mediated innate immune response in patients with alcoholic chronic liver disease

Background: Alcoholic chronic liver disease (ACLD) is a common form of acquired immunodeficiency.

[1]  P. Angus,et al.  Effects of antibiotics on expression and function of Toll-like receptors 2 and 4 on mononuclear cells in patients with advanced cirrhosis. , 2010, Journal of hepatology.

[2]  John D. Scott,et al.  Chronic liver disease in Aboriginal North Americans. , 2008, World journal of gastroenterology.

[3]  R. Jalan,et al.  Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. , 2008, Journal of hepatology.

[4]  Holger Heine,et al.  Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling , 2008, Journal of leukocyte biology.

[5]  T. Hawn,et al.  Differential Constitutive and Cytokine-Modulated Expression of Human Toll-like Receptors in Primary Neutrophils, Monocytes, and Macrophages , 2008, International journal of medical sciences.

[6]  A. Órfão,et al.  Production of inflammatory cytokines by peripheral blood monocytes in chronic alcoholism: Relationship with ethanol intake and liver disease , 2007, Cytometry. Part B, Clinical cytometry.

[7]  M. Falagas,et al.  Bacterial Infection-Related Morbidity and Mortality in Cirrhosis , 2007, The American Journal of Gastroenterology.

[8]  I. Sheen,et al.  Endotoxemia contributes to the immune paralysis in patients with cirrhosis. , 2007, Journal of hepatology.

[9]  R. Xu,et al.  Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: Role in proliferation and apoptosis in the intestine. , 2006, Gastroenterology.

[10]  R. Moreau,et al.  Upregulation of TNF-alpha production signaling pathways in monocytes from patients with advanced cirrhosis: possible role of Akt and IRAK-M. , 2006, Journal of hepatology.

[11]  Wangxue Chen,et al.  Role of Toll-like receptors in health and diseases of gastrointestinal tract. , 2006, World journal of gastroenterology.

[12]  F. Căruntu,et al.  Spontaneous bacterial peritonitis: pathogenesis, diagnosis, treatment. , 2006, Journal of gastrointestinal and liver diseases : JGLD.

[13]  H. S. Warren,et al.  Toll-like receptors. , 2005, Critical care medicine.

[14]  P. Thompson,et al.  Modulatory effects of sCD14 and LBP on LPS-host cell interactions , 2005, Journal of endotoxin research.

[15]  B. Runyon,et al.  Spontaneous Bacterial Peritonitis , 2005, Digestive Diseases.

[16]  G. Garcia‐Tsao.  Bacterial infections in cirrhosis: treatment and prophylaxis. , 2005, Journal of hepatology.

[17]  R. Wiest,et al.  Bacterial translocation (BT) in cirrhosis , 2005, Hepatology.

[18]  F. Lammert,et al.  Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. , 2005, Journal of hepatology.

[19]  Shizuo Akira,et al.  Pleiotropic function of Toll-like receptors. , 2004, Microbes and infection.

[20]  W. Schrödl,et al.  Chronic alcoholism causes deleterious conditioning of innate immunity. , 2004, Alcohol and alcoholism.

[21]  C. McClain,et al.  Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[22]  A. Eley,et al.  Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via toll-like receptor 2. , 2004, Journal of medical microbiology.

[23]  J. Rodés,et al.  Bacterial infections in cirrhosis , 2004, Liver international : official journal of the International Association for the Study of the Liver.

[24]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[25]  R. Wiest,et al.  Gut microflora in the pathogenesis of the complications of cirrhosis. , 2004, Best practice & research. Clinical gastroenterology.

[26]  M. Greenblatt,et al.  A Toll-like Receptor That Prevents Infection by Uropathogenic Bacteria , 2004, Science.

[27]  R. Medzhitov,et al.  Recognition of microbial infection by Toll-like receptors. , 2003, Current opinion in immunology.

[28]  L. Wetzler.  The role of Toll-like receptor 2 in microbial disease and immunity. , 2003, Vaccine.

[29]  Roger Williams,et al.  Peripheral blood mononuclear cell expression of toll‐like receptors and relation to cytokine levels in cirrhosis , 2003, Hepatology.

[30]  U. Böcker,et al.  Differential expression of toll-like receptors 2 and 4 in patients with liver cirrhosis , 2003, European journal of gastroenterology & hepatology.

[31]  C. Jefferies,et al.  Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors , 2003, Journal of endotoxin research.

[32]  F. Foschi,et al.  Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome , 2002, Gut.

[33]  J. Kolls,et al.  Alcohol, host defence and society , 2002, Nature Reviews Immunology.

[34]  R. Munford,et al.  Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins. , 2001, The Journal of clinical investigation.

[35]  D. Golenbock,et al.  Membrane-Associated Proteins of a Lipopolysaccharide-Deficient Mutant of Neisseria meningitidis Activate the Inflammatory Response through Toll-Like Receptor 2 , 2001, Infection and Immunity.

[36]  R. McCuskey,et al.  Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease. , 2001, Alcoholism, clinical and experimental research.

[37]  W. Buurman,et al.  LPS-binding protein circulates in association with apoB-containing lipoproteins and enhances endotoxin-LDL/VLDL interaction. , 2001, The Journal of clinical investigation.

[38]  J. Tellado,et al.  In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. , 2000, The Journal of infectious diseases.

[39]  M. Plauth,et al.  Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation , 2000, Gut.

[40]  S. Akira,et al.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. , 1999, Immunity.

[41]  R. M. Wooten,et al.  Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. , 1999, Journal of immunology.

[42]  D. Golenbock,et al.  Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. , 1999, Journal of immunology.

[43]  M. Rothe,et al.  Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2* , 1999, The Journal of Biological Chemistry.

[44]  G. Hardiman,et al.  A family of human receptors structurally related to Drosophila Toll. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. Fearon.  Seeking wisdom in innate immunity , 1997, Nature.

[46]  N. Graudal,et al.  Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. , 1997, Gut.

[47]  C. Müller,et al.  Increased in vitro production and serum levels of the soluble lipopolysaccharide receptor sCD14 in liver disease. , 1995, Journal of hepatology.

[48]  S. D. Lee,et al.  Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. , 1995, Journal of hepatology.

[49]  A. Schreiber,et al.  Impaired Function of Macrophage Fcγ Receptors and Bacterial Infection in Alcoholic Cirrhosis , 1994 .

[50]  H. Tilg,et al.  Serum levels of cytokines in chronic liver diseases. , 1992, Gastroenterology.

[51]  C. Bode,et al.  Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. , 1991, Journal of hepatology.

[52]  J. Bauer,et al.  Effects of cytokines on the liver , 1991, Hepatology.

[53]  A. Khoruts,et al.  Circulating tumor necrosis factor, interleukin‐1 and interleukin‐6 concentrations in chronic alcoholic patients , 1991, Hepatology.

[54]  R. Macgregor.  Alcohol and immune defense. , 1986, JAMA.

[55]  R. Pugh,et al.  Transection of the oesophagus for bleeding oesophageal varices , 1973, The British journal of surgery.

[56]  R. Brůha,et al.  Alcoholic liver disease. , 2012, World journal of hepatology.

[57]  E. Goldstein,et al.  Opsonophagocytic dysfunction in patients with liver cirrhosis and low responses to tumor necrosis factor-α and lipopolysaccharide in patients’ blood , 2004, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[58]  C. McClain,et al.  Cytokines in Alcoholic Liver Disease , 1999, Seminars in liver disease.

[59]  S. Pillai,et al.  Innate immunity. , 1996, Current opinion in immunology.

[60]  A. Schreiber,et al.  Impaired function of macrophage Fc gamma receptors and bacterial infection in alcoholic cirrhosis. , 1994, The New England journal of medicine.